The pathophysiology of COVID-19 starts with SARS-CoV-2’s initial contact and subsequent entrance through the cell’s membrane-bound angiotensin-converting enzyme 2 (ACE2) receptor (Fig. 1). This evidence concerns the gene ACE2 and COVID-19.